Recent observations have provided convincing evidence to suggest that miR-200 family members (miR-200a, miR-200b, miR-200c, miR-141, and miR-429) and miR-205 can activate EMT by targeting the EMT drivers ZEB1 and ZEB2 in various cancer types, including ovarian cancer [28–30]. This evidence concerns the gene ZEB1 and cancer.